We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Non-Contrast-Enhanced Multiparametric MRI of the Hypoxic Tumor Microenvironment Allows Molecular Subtyping of Breast Cancer: A Pilot Study.
- Authors
Bartsch, Silvester J.; Brožová, Klára; Ehret, Viktoria; Friske, Joachim; Fürböck, Christoph; Kenner, Lukas; Laimer-Gruber, Daniela; Helbich, Thomas H.; Pinker, Katja
- Abstract
Simple Summary: Breast cancer, the second-leading cause of mortality among women worldwide, is often diagnosed through invasive tissue sampling. This method may not fully represent the tumor's overall physiology, potentially leading to suboptimal treatment strategies and tumor recurrence. A non-invasive approach using MRI to quantify the hypoxic environment within the tumor could significantly enhance the accuracy of breast-cancer-subtype prediction. Our study introduces non-invasive imaging markers for hypoxia and related angiogenesis, utilizing hyperoxic-blood-oxygen-level-dependent (BOLD)-MRI and intravoxel-incoherent-motion (IVIM)-MRI techniques. These markers correlate with microvessel density and maturity as assessed by histology, enabling the distinction between the less aggressive luminal A and the more aggressive triple-negative breast cancers. Tumor neoangiogenesis is an important hallmark of cancer progression, triggered by alternating selective pressures from the hypoxic tumor microenvironment. Non-invasive, non-contrast-enhanced multiparametric MRI combining blood-oxygen-level-dependent (BOLD) MRI, which depicts blood oxygen saturation, and intravoxel-incoherent-motion (IVIM) MRI, which captures intravascular and extravascular diffusion, can provide insights into tumor oxygenation and neovascularization simultaneously. Our objective was to identify imaging markers that can predict hypoxia-induced angiogenesis and to validate our findings using multiplexed immunohistochemical analyses. We present an in vivo study involving 36 female athymic nude mice inoculated with luminal A, Her2+, and triple-negative breast cancer cells. We used a high-field 9.4-tesla MRI system for imaging and subsequently analyzed the tumors using multiplex immunohistochemistry for CD-31, PDGFR-β, and Hif1-α. We found that the hyperoxic-BOLD-MRI-derived parameter ΔR2* discriminated luminal A from Her2+ and triple-negative breast cancers, while the IVIM-derived parameter fIVIM discriminated luminal A and Her2+ from triple-negative breast cancers. A comprehensive analysis using principal-component analysis of both multiparametric MRI- and mpIHC-derived data highlighted the differences between triple-negative and luminal A breast cancers. We conclude that multiparametric MRI combining hyperoxic BOLD MRI and IVIM MRI, without the need for contrast agents, offers promising non-invasive markers for evaluating hypoxia-induced angiogenesis.
- Subjects
BIOLOGICAL models; PILOT projects; CARDIOVASCULAR system physiology; NEOVASCULARIZATION inhibitors; OXYGEN; ANIMAL experimentation; IMMUNOHISTOCHEMISTRY; MAGNETIC resonance imaging; CELL physiology; CANCER relapse; OXYGEN saturation; BACTERIOPHAGE typing; DESCRIPTIVE statistics; RESEARCH funding; SENSITIVITY &; specificity (Statistics); BREAST tumors; HYPOXEMIA; MICE
- Publication
Cancers, 2024, Vol 16, Issue 2, p375
- ISSN
2072-6694
- Publication type
Article
- DOI
10.3390/cancers16020375